Effects of central angiotensin II receptor antagonism on fetal swallowing and cardiovascular activity.
D000704:Analysis of Variance; D000804:Angiotensin II / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D003679:Deglutition / Q000187:drug effects / Q000502:physiology*; D004195:Disease Models, Animal; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005333:Fetus / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D007276:Injections, Intraventricular; D011247:Pregnancy; D011270:Pregnancy, Animal; D011336:Probability; D011945:Receptors, Angiotensin / Q000187:drug effects*; D012016:Reference Values; D012504:Saralasin / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D012756:Sheep